文献速递产科母胎医学

妊娠早期母体肾素-血管紧张素-醛固酮系统激活与胎儿生长及出生体重:鹿特丹围受孕期队列研究

First-trimester maternal renin-angiotensin-aldosterone system activation and fetal growth and birthweight: the Rotterdam Periconceptional Cohort.
PubMed 文献 · Reprod Biomed Online · 2022-01-19

从鹿特丹围受孕期队列选取201例持续妊娠,于孕9周和11周检测血浆肾素、肾素原和醛固酮,并追踪早期和晚期胎儿生长及出生体重。孕11周肾素原浓度与晚期胎儿生长和出生体重呈显著负相关,且与小于胎龄儿风险升高相关;醛固酮/肾素比值与小于胎龄儿风险呈负相关。在总队列(n=1401)中,黄体数>1的妊娠出生体重百分位低于黄体数为1的妊娠。

要点

  • 孕11周肾素原浓度与晚期胎儿生长(β -0.07)及出生体重(βz评分 -0.28)呈显著负相关。
  • 孕11周肾素原浓度升高与小于胎龄儿(<p10)风险增加相关(OR 10.47)。
  • 醛固酮/肾素比值与小于胎龄儿风险呈负相关(OR 0.38)。

核心结论

  • 妊娠早期肾素原释放过多导致血管紧张素上调,可解释黄体数>1的妊娠后代出生体重降低和小于胎龄儿风险。
  • 醛固酮高浓度独立于肾素,似乎具有有益影响。

研究设计与样本

  • 研究类型为队列研究,样本来自鹿特丹围受孕期队列,共201例持续妊娠,其中104例自然受孕、7例单次宫内人工授精(IUI)后、8例IUI联合促排卵后、82例体外受精或卵胞浆内单精子注射后。
  • 于孕9周和11周检测血浆肾素、肾素原和醛固酮浓度。
  • 采用虚拟现实软件测量孕7、9、11周头臀长和胚胎体积以评估早期胎儿生长。
  • 测量孕22周和32周估计胎儿体重及出生体重以评估晚期胎儿生长轨迹。
  • 从医疗记录获取妊娠结局、小于胎龄儿(SGA,<p10)和出生体重。

主要发现

  • 孕11周肾素原浓度与晚期胎儿生长呈显著负相关(β -0.07,95%CI -0.11至-0.03,P<0.001)。
  • 孕11周肾素原浓度与出生体重呈显著负相关(βz评分 -0.28,95%CI -0.55至-0.01,P=0.03)。
  • 孕11周肾素原浓度与小于胎龄儿(<p10)风险增加相关(OR 10.47,95%CI 2.49至53.21,P=0.002)。
  • 醛固酮/肾素比值与小于胎龄儿风险呈负相关(OR 0.38,95%CI 0.15至0.91,P=0.03)。
  • 在总鹿特丹围受孕期队列(n=1401)中,黄体数>1的妊娠出生体重百分位低于黄体数为1的妊娠(βz评分 -0.17,95%CI -0.32至-0.01,P=0.04)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Does first-trimester maternal renin-angiotensin-aldosterone system (RAAS) activity determine early and late fetal growth and birthweight? DESIGN: A total of 201 ongoing pregnancies, of which 104 were conceived naturally, seven following single intrauterine insemination (IUI), eight after IUI with ovulation induction and 82 after IVF or intracytoplasmic sperm injection treatment were selected from the Rotterdam Periconceptional Cohort. Renin, prorenin and aldosterone concentrations were determined in blood plasma at 9 and 11 weeks of gestational age. Serial crown-rump length and embryonic volume at 7, 9 and 11 weeks of gestational age were measured using virtual reality software to assess early fetal growth. Estimated fetal weight at 22 and 32 weeks of gestational age and birthweight were measured to assess late fetal growth trajectories. Pregnancy outcomes, small for gestational age (SGA) (<p10) and birthweight were retrieved from medical records. RESULTS: Prorenin concentrations at 11 weeks of gestation showed significant negative associations with late fetal growth (beta -0.07, 95% CI -0.11 to -0.03, P < 0.001) and birthweight (betaz-scores -0.28, 95% CI -0.55 to -0.01, P=0.03), and an increased risk of SGA (<p10) (OR 10.47, 95% CI 2.49 to 53.21, P=0.002). The aldosterone/renin ratio associated negatively with the risk of SGA (OR 0.38, 95% CI 0.15 to 0.91, P=0.03). In addition, adjusted linear regression models using the total Rotterdam Periconceptional Cohort (n=1401) confirmed decreased birthweight percentiles in pregnancies with >1 corpus luteum versus pregnancies with 1 corpus luteum (betaz-scores -0.17, 95% CI -0.32 to -0.01, P=0.04). CONCLUSION: This study shows that excessive first-trimester prorenin release, resulting in angiotensin up-regulation, can explain why pregnancies with >1 corpus luteum are at risk for offspring with decreased birthweight and SGA. Simultaneously, high concentrations of aldosterone, independent of renin, seem to have a beneficial influence.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Wiegel RE, Aoulad Fares D, Willemsen SP, et al. First-trimester maternal renin-angiotensin-aldosterone system activation and fetal growth and birthweight: the Rotterdam Periconceptional Cohort. Reprod Biomed Online. 2022. PMID: 35379566. doi:10.1016/j.rbmo.2021.12.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。